A Mathematical Model of the Enhancement of Tumor Vaccine Efficacy by Immunotherapy
暂无分享,去创建一个
[1] Xuedong Liu,et al. Decoding the quantitative nature of TGF-beta/Smad signaling. , 2008, Trends in cell biology.
[2] D. Kirschner,et al. A mathematical model of tumor-immune evasion and siRNA treatment , 2003 .
[3] Helen M. Byrne,et al. The role of growth factors in avascular tumour growth , 1997 .
[4] S. Rosenberg,et al. Cancer immunotherapy: moving beyond current vaccines , 2004, Nature Medicine.
[5] A. Perelson,et al. Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis. , 1994, Bulletin of mathematical biology.
[6] M. Reiss. TGF- and cancer , 1999 .
[7] D. Hafler,et al. FOXP3+ regulatory T cells in the human immune system , 2010, Nature Reviews Immunology.
[8] J. Prieto,et al. Peptide inhibitors of transforming growth factor‐β enhance the efficacy of antitumor immunotherapy , 2009, International journal of cancer.
[9] A. Cerwenka,et al. TGF-β1: immunosuppressant and viability factor for T lymphocytes , 1999 .
[10] Mikhail K. Kolev,et al. A mathematical model for single cell cancer - Immune system dynamics , 2005, Math. Comput. Model..
[11] A. Radunskaya,et al. Mixed Immunotherapy and Chemotherapy of Tumors: Modeling, Applications and Biological Interpretations , 2022 .
[12] G. Currie. Eighty years of immunotherapy: a review of immunological methods used for the treatment of human cancer. , 1972, British Journal of Cancer.
[13] J. Leith,et al. Autocrine and paracrine growth factors in tumor growth: a mathematical model. , 1991, Bulletin of mathematical biology.
[14] Haiwen Tang. Cancer vaccines and immunotherapy , 2009, Human vaccines.
[15] S. Sakaguchi. Regulatory T cells , 2000, Cell.
[16] L. D. Pillis,et al. A Validated Mathematical Model of Cell-Mediated Immune Response to Tumor Growth , 2005 .
[17] A. Liston,et al. Regulatory T Cells , 2011, Methods in Molecular Biology.
[18] Yuri Kogan,et al. Cellular Immunotherapy for High Grade Gliomas: Mathematical Analysis Deriving Efficacious Infusion Rates Based on Patient Requirements , 2010, SIAM J. Appl. Math..
[19] Zvia Agur,et al. Cancer immunotherapy by interleukin-21: potential treatment strategies evaluated in a mathematical model. , 2006, Cancer research.
[20] Steven A. Rosenberg,et al. Progress in human tumour immunology and immunotherapy , 2001, Nature.
[21] D. Earn,et al. Interactions Between the Immune System and Cancer: A Brief Review of Non-spatial Mathematical Models , 2011, Bulletin of mathematical biology.
[22] M. Beyer,et al. Regulatory T cells in cancer. , 2006, Blood.
[23] Allan Balmain,et al. TGF-β signaling in tumor suppression and cancer progression , 2001, Nature Genetics.
[24] T. Nomura,et al. Regulatory T Cells and Immune Tolerance , 2008, Cell.
[25] J. Blattman,et al. Cancer Immunotherapy: A Treatment for the Masses , 2004, Science.
[26] Rustom Antia,et al. Estimating the Precursor Frequency of Naive Antigen-specific CD8 T Cells , 2002, The Journal of experimental medicine.
[27] Richard A. Flavell,et al. The polarization of immune cells in the tumour environment by TGFβ , 2010, Nature Reviews Immunology.
[28] Antoni Ribas,et al. Current developments in cancer vaccines and cellular immunotherapy. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] J. Berzofsky,et al. Synergistic Enhancement of CD8+ T Cell–Mediated Tumor Vaccine Efficacy by an Anti–Transforming Growth Factor-β Monoclonal Antibody , 2009, Clinical Cancer Research.
[30] F. Paillard. Immunosuppression mediated by tumor cells: a challenge for immunotherapeutic approaches. , 2000, Human gene therapy.
[31] Doron Levy,et al. Emergent Group Dynamics Governed by Regulatory Cells Produce a Robust Primary T Cell Response , 2010, Bulletin of mathematical biology.
[32] A. d’Onofrio. A general framework for modeling tumor-immune system competition and immunotherapy: Mathematical analysis and biomedical inferences , 2005, 1309.3337.
[33] R. Derynck,et al. TGF-β signaling in cancer – a double-edged sword , 2001 .
[34] S. Schnell,et al. A multiscale mathematical model of cancer, and its use in analyzing irradiation therapies , 2006, Theoretical Biology and Medical Modelling.
[35] Doron Levy,et al. Modeling regulation mechanisms in the immune system. , 2007, Journal of theoretical biology.
[36] Nicole S. Bryce,et al. A mathematical model quantifies proliferation and motility effects of TGF-β on cancer cells. , 2007, Computational and mathematical methods in medicine.
[37] Benedetto Piccoli,et al. Optimal Control in a Model of Dendritic Cell Transfection Cancer Immunotherapy , 2006, 2004 43rd IEEE Conference on Decision and Control (CDC) (IEEE Cat. No.04CH37601).
[38] Shelby N. Wilson,et al. A Mathematical Model of the Primary T Cell Response with Contraction Governed by Adaptive Regulatory T Cells , 2010 .
[39] D. Kirschner,et al. Modeling immunotherapy of the tumor – immune interaction , 1998, Journal of mathematical biology.